PolarityTE, Inc. (PTE)
NASDAQ: PTE · IEX Real-Time Price · USD
1.38
-0.24 (-14.81%)
At close: Aug 12, 2022 4:00 PM
1.39
+0.01 (0.72%)
After-hours:
Aug 12, 2022 7:50 PM EDT
PolarityTE Market Cap
PolarityTE has a market cap or net worth of $7.23 million as of August 14, 2022, making it the 6,218th biggest public company in the US. PolarityTE's market cap has decreased by -88.59% in one year.
Market Cap
7.23M
Enterprise Value
-13.22M
1-Year Change
-88.59%
Ranking
Category
Nano-Cap
Stock Price
$1.38
Market Cap Chart
Since August 17, 1999, PolarityTE's market cap has decreased from $45.22 million to $7.23 million, a decrease of -84.01%. That is a compound annual growth rate of -7.66%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 12, 2022 | 7.23M | - |
Aug 11, 2022 | 7.23M | 3.85% |
Aug 10, 2022 | 6.96M | - |
Aug 9, 2022 | 6.96M | -5.46% |
Aug 8, 2022 | 7.37M | 7.14% |
Aug 5, 2022 | 6.88M | 1.10% |
Aug 4, 2022 | 6.80M | 1.80% |
Aug 3, 2022 | 6.68M | 9.23% |
Aug 2, 2022 | 6.12M | 3.01% |
Aug 1, 2022 | 5.94M | -0.75% |
Jul 29, 2022 | 5.98M | 4.69% |
Jul 28, 2022 | 5.71M | 9.05% |
Jul 27, 2022 | 5.24M | -0.76% |
Jul 26, 2022 | 5.28M | -17.29% |
Jul 25, 2022 | 6.38M | -4.02% |
Jul 22, 2022 | 6.65M | - |
Jul 21, 2022 | 6.65M | -1.97% |
Jul 20, 2022 | 6.79M | 15.40% |
Jul 19, 2022 | 5.88M | -0.68% |
Jul 18, 2022 | 5.92M | 0.68% |
Jul 15, 2022 | 5.88M | -6.37% |
Jul 14, 2022 | 6.28M | -9.24% |
Jul 13, 2022 | 6.92M | -1.90% |
Jul 12, 2022 | 7.05M | -1.25% |
Jul 11, 2022 | 7.14M | - |
View and export this data all the way back to 1999.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition
Related Stocks
Company | Market Cap |
---|---|
Histogen | 5.02M |
Bellerophon Therapeutics | 13.55M |
Guardion Health Sciences | 10.61M |
SCWorx | 9.31M |
PainReform | 8.30M |
Creative Medical Technology Holdings | 7.25M |
GBS, Inc. | 10.57M |
Hillstream BioPharma | 13.46M |
Scopus Biopharma | 9.49M |